Personalized GI Motility Responses to Diet
Launched by UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · Apr 23, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Personalized GI Motility Responses to Diet," aims to investigate how different types of grains—whole grains versus refined grains—affect the way our digestive system works and how these foods influence our overall health. Researchers want to understand how eating these grains changes the movement of food through the gut, the production of useful substances by gut bacteria, and the levels of important health markers like blood sugar and cholesterol after eating.
The study is looking for healthy men and women aged 18 to 65 who do not have certain medical conditions like diabetes, gastrointestinal disorders, or who have not recently taken antibiotics. Participants will wear a small device that tracks how their stomach and intestines respond to meals over an 8-hour period and will also provide a stool sample to help researchers learn more about their gut bacteria. If you join the trial, you’ll help us better understand how our diet can impact our gut health and overall well-being!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy men and women
- Exclusion Criteria:
- Physician-Diagnosed:
- • Diabetes Mellitus
- • Nutrient-malabsorption disorders
- • Intestinal Bowel Syndrome (IBS)
- • Intestinal Bowel Disease (IBD)
- • Bleeding-related disorders
- • Grain allergy
- • Psychological Disorders
- • Stenosis
- • Dysphasia
- History of:
- • Bariatric Surgery
- • Gallbladder removal
- • Eating disorders
- • Antibiotic administration (within the past three months)
- • Hormone therapy
- Currently:
- • Using statins
- • Pregnant, lactating, or postmenopausal
- • Taking oral hypoglycemic agents or insulin
- • Ingesting prescription fiber
- • Using cholesterol and bile acid absorption inhibitors
- • Ingesting nutrition supplements, not including a daily multivitamin (i.e. herbs, tinctures, and extracts) •Using recreational drugs or alcohol (within the past week)
- • Taking anti-histamines
- • Taking proton pump inhibitors
- • Taking antacids
About University Of Illinois At Urbana Champaign
The University of Illinois at Urbana-Champaign is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. With a strong commitment to rigorous scientific inquiry, the university conducts clinical trials aimed at improving patient outcomes and understanding complex health challenges. Leveraging its multidisciplinary expertise and state-of-the-art facilities, the university collaborates with healthcare professionals and researchers to explore novel therapeutic interventions and enhance evidence-based practices. Through its clinical trials, the University of Illinois at Urbana-Champaign strives to contribute significantly to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Urbana, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported